CD4 and neoplasm: Loss of responsiveness to IFN-γ provides an immune escape mechanism for many human tumors, yet tumor sensitivity to IFN-γ was not required for inhibition of tumor angiogenesis or infiltration of CD4+ and CD8+ T cells to the tumor site in response to Lm-LLO-E7 in preclinical models [37].